AMSTERDAM, THE NETHERLANDS--(Marketwired - Sep 28, 2015) - Holaira, Inc., a developer of medical devices to treat obstructive lung diseases, announced it will host a mini-symposium on Targeted Lung ...
A first for Temple University Hospital and U.S. Patients MINNEAPOLIS, June 10, 2019 /CNW/ -- Nuvaira, developer of novel therapeutic strategies to treat obstructive lung diseases, announced the first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results